<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01835639</url>
  </required_header>
  <id_info>
    <org_study_id>12-009753</org_study_id>
    <secondary_id>K23DK093556</secondary_id>
    <nct_id>NCT01835639</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation in Glomerular Disease</brief_title>
  <official_title>Pilot Study: Efficacy and Safety of Vitamin D Supplementation in Glomerular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Society of Nephrology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The NephCure Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Philadelphia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multi-site, pilot study will assess vitamin D supplementation in children and young
      adults with Glomerular Disease. .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D deficiency has been linked to a variety of adverse health outcomes. Nephrotic
      patients have very low vitamin D levels, and the underlying mechanisms are not known.
      Furthermore, approaches to safely and effectively supplement vitamin D in these patients have
      not been established. The purpose of this research study is to learn if vitamin D
      supplementation is safe and effective in patients with primary glomerular disease and to also
      help establish the treatment guidelines. About 35 patients with primary glomerular disease,
      ages 5-30 years old, will take part in this study. Participants will be asked to take vitamin
      D supplements each day for 12 weeks and will have 3 study visits.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    slow accrual and Investigators seek to evaluate the study status and data
  </why_stopped>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the efficacy of vitamin D supplementation, by the increase in total and free 25(OH)D levels.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the safety of vitamin D supplementation, by serum Ionized calcium (ICal), Pi, and 25(OH)D, and urinary calcium excretion.</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the innate immune response, measured by changes in the induction of Human cathelicidin antimicrobial protein (hCAP) in human monocytes.</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess intra-renal inflammation, measured by changes in urinary Macrophage chemo-attractant protein 1 (MCP-1).</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess arterial stiffness, measured by changes in pulse wave velocity.</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Glomerular Disease</condition>
  <arm_group>
    <arm_group_label>Vitamin D Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cholecalciferol, 2000 or 4000 IUs by mouth daily for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cholecalciferol, 2000 or 4000 IUs by mouth daily for 12 weeks</intervention_name>
    <description>Supplements will be provided as oral capsules.</description>
    <arm_group_label>Vitamin D Supplementation</arm_group_label>
    <other_name>Vitamin D</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females, age 5-30 years

          -  Diagnosis of primary glomerular disease (such as steroid-resistant nephrotic syndrome,
             minimal change disease, FSGS, membranous nephropathy, membranoprolfierative
             glomerulonephritis, and Immunoglobulin A [IgA] nephropathy) without systemic
             inflammatory disorders (i.e. lupus, vasculitis)

          -  Serum 25(OH)D level &lt;30 ng/ml and urine protein:creatinine ratio â‰¥0.5 at Screening
             Visit.

        Exclusion Criteria:

          -  Pregnancy

          -  estimated Glomerular Filtration Rate (eGFR) &lt;30 ml/min/1.73m2 at Screening Visit

          -  Serum phosphorus &gt; 5.5 mg/dl or hypercalcemia

          -  Chronic medical conditions or medications unrelated to the renal disease that may
             impact vitamin D status

          -  Known history of kidney stone(s)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle Denburg, MD, MSCE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Philadelphia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nemours/Alfred I. duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University,Division of Pediatric Nephrology</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore-Long Island Jewish Health System</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2013</study_first_submitted>
  <study_first_submitted_qc>April 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2013</study_first_posted>
  <last_update_submitted>November 6, 2017</last_update_submitted>
  <last_update_submitted_qc>November 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glomerular Disease</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Steroid-resistant nephrotic syndrome</keyword>
  <keyword>Minimal change disease</keyword>
  <keyword>Focal segmental glomerulosclerosis (FSGS)</keyword>
  <keyword>Membranous Nephropathy</keyword>
  <keyword>Membranoprolfierative Glomerulonephritis</keyword>
  <keyword>immunoglobulin A (IgA) Nephropathy</keyword>
  <keyword>FSGS</keyword>
  <keyword>IgA Nephropathy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

